Dear Sir/Madam, Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 please find the attached certificate for the quarter ended 31st March, 2025. Thanking You.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has submitted a routine compliance certificate from its Registrar and Share Transfer Agent, Purva Sharegistry (I) Pvt. Ltd., for the quarter ended 31 March 2025. The certificate confirms that the RTA has processed all share certificates received for dematerialisation and updated the register of members within prescribed timelines. The accompanying dematerialisation details show NIL shares were converted from physical to electronic form during 1 January 2025 to 31 March 2025. The company is listed on both BSE (Scrip Code: 512217) and MSE (Symbol: PRISMMEDI). Signed by Director Davender Singh (DIN: 09447213).
This is a procedural regulatory compliance filing with no material business or price impact. The NIL dematerialisation activity indicates no investor requests for converting physical shares to electronic form during the quarter, suggesting limited trading or transfer activity in the stock.